INTERNATIONAL PATENT: INSTITUTE FOR CANCER RESEARCH D/B/A THE RESEARCH INSTITUTE OF FOX CHASE CANCER CENTER FILES APPLICATION FOR "COMPOSITIONS AND METHODS FOR INHIBITING DNMT1 METHYLATION ACTIVITY FOR REDUCING CHEMOTHERAPY INDUCED AMPLIFICATION AND REARRANGEMENT IN MIXED LINEAGE LEUKEMIA (MLL)"

GENEVA, Feb. 4 -- INSTITUTE FOR CANCER RESEARCH D/B/A THE RESEARCH INSTITUTE OF FOX CHASE CANCER CENTER (333 Cottman AvenuePhiladelphia, PA 19111-2497) filed a patent application (PCT/US2025/039448) for "COMPOSITIONS AND METHODS FOR INHIBITING DNMT1 METHYLATION ACTIVITY FOR REDUCING CHEMOTHERAPY INDUCED AMPLIFICATION AND REARRANGEMENT IN MIXED LINEAGE LEUKEMIA (MLL)" on Jul 28, 2025. With publication no. WO/2026/025099, the details related to the patent application was published on Jan 29, 2026.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): WHETSTINE, Johnathan, R. (1190 Fairland DriveAmbler, PA...